View this meeting on demand to learn about the pathogenesis of peripheral arterial disease (PAD) and coronary artery disease (CAD) and the distinct clinical trajectories of the decisions that should inform treatment decision making. Accreditation Statement In accordance with ACCME policy, prior to participating in this activity, you must review the information on this page.
Joint Accreditation In support of improving patient care, the American College of Cardiology Foundation (ACCF) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
Credit Statement
Physicians
The ACCF designates this online enduring material for a maximum of up to 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
MOCSuccessful completion of this JACC Journal CME/MOC activity, which includes participation in the evaluation component, enables the participant to earn up to 1 Medical Knowledge MOC point in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program.Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.
Target Audience: The primary target audience for this education includes cardiologists and vascular specialists, and the secondary audience is the CV team, including nurse practitioners, registered nurses, physician assistants and pharmacists.
Important Dates: Date of Release: June 22, 2023Term of Approval/Date of Expiration: June 30, 2024 Learner Objectives:
Upon completion, learners should be able to:
Review atherosclerosis and identify the differences between coronary and peripheral artery disease.
Describe thrombotic cascade and the effects of each component on atherosclerosis.
Compare the various antithrombotic therapies including mechanism of action and pharmacokinetics of antiplatelets and anticoagulants.
Evaluate clinical trial outcomes for various antithrombotic therapies for the treatment of coronary and peripheral atherosclerosis.
Acknowledgements:Educational grant support provided by: Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.
Faculty:
Kelley R.H. Branch, MD, MSc, FACC Roxana Mehran, MD, FACC Marc P. Bonaca, MD, MPH Geoffrey D. Barnes, MD, MSc, FACC